These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10754311

  • 1. Mass spectrometric characterization of a discontinuous epitope of the HIV envelope protein HIV-gp120 recognized by the human monoclonal antibody 1331A.
    Hochleitner EO, Gorny MK, Zolla-Pazner S, Tomer KB.
    J Immunol; 2000 Apr 15; 164(8):4156-61. PubMed ID: 10754311
    [Abstract] [Full Text] [Related]

  • 2. The HIV-neutralizing monoclonal antibody 4E10 recognizes N-terminal sequences on the native antigen.
    Hager-Braun C, Katinger H, Tomer KB.
    J Immunol; 2006 Jun 15; 176(12):7471-81. PubMed ID: 16751393
    [Abstract] [Full Text] [Related]

  • 3. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.
    Virology; 1998 Nov 10; 251(1):59-70. PubMed ID: 9813203
    [Abstract] [Full Text] [Related]

  • 4. Characterization of a discontinuous epitope of the human immunodeficiency virus (HIV) core protein p24 by epitope excision and differential chemical modification followed by mass spectrometric peptide mapping analysis.
    Hochleitner EO, Borchers C, Parker C, Bienstock RJ, Tomer KB.
    Protein Sci; 2000 Mar 10; 9(3):487-96. PubMed ID: 10752610
    [Abstract] [Full Text] [Related]

  • 5. Matrix-assisted laser desorption ionization/mass spectrometry mapping of human immunodeficiency virus-gp120 epitopes recognized by a limited polyclonal antibody.
    Jeyarajah S, Parker CE, Summer MT, Tomer KB.
    J Am Soc Mass Spectrom; 1998 Feb 10; 9(2):157-65. PubMed ID: 9679595
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a discontinuous epitope of the HIV envelope protein gp120 recognized by a human monoclonal antibody using chemical modification and mass spectrometric analysis.
    Hager-Braun C, Hochleitner EO, Gorny MK, Zolla-Pazner S, Bienstock RJ, Tomer KB.
    J Am Soc Mass Spectrom; 2010 Oct 10; 21(10):1687-98. PubMed ID: 20434359
    [Abstract] [Full Text] [Related]

  • 7. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
    Lusso P, Earl PL, Sironi F, Santoro F, Ripamonti C, Scarlatti G, Longhi R, Berger EA, Burastero SE.
    J Virol; 2005 Jun 10; 79(11):6957-68. PubMed ID: 15890935
    [Abstract] [Full Text] [Related]

  • 8. NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.
    Tugarinov V, Zvi A, Levy R, Hayek Y, Matsushita S, Anglister J.
    Structure; 2000 Apr 15; 8(4):385-95. PubMed ID: 10801487
    [Abstract] [Full Text] [Related]

  • 9. Anti-human immunodeficiency virus type 1 human monoclonal antibodies that bind discontinuous epitopes in the viral glycoproteins can identify mimotopes from recombinant phage peptide display libraries.
    Boots LJ, McKenna PM, Arnold BA, Keller PM, Gorny MK, Zolla-Pazner S, Robinson JE, Conley AJ.
    AIDS Res Hum Retroviruses; 1997 Dec 10; 13(18):1549-59. PubMed ID: 9430247
    [Abstract] [Full Text] [Related]

  • 10. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD, Schellekens MM, Lewis GK, Moore JP, Matthews TJ, Langedijk JP, Meloen RH, Boersma WJ, Claassen E.
    AIDS Res Hum Retroviruses; 1993 Jul 10; 9(7):605-12. PubMed ID: 8369165
    [Abstract] [Full Text] [Related]

  • 11. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K, Durani V, Miranda ER, Citron M, Liang X, Schleif W, Joyce JG, Varadarajan R.
    Biochem J; 2006 Nov 01; 399(3):483-91. PubMed ID: 16827663
    [Abstract] [Full Text] [Related]

  • 12. Structural and functional characterization of an epitope in the conserved C-terminal region of HIV-1 gp120.
    Ferrer M, Sullivan BJ, Godbout KL, Burke E, Stump HS, Godoy J, Golden A, Profy AT, van Schravendijk MR.
    J Pept Res; 1999 Jul 01; 54(1):32-42. PubMed ID: 10448968
    [Abstract] [Full Text] [Related]

  • 13. Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T.
    Macht M, Fiedler W, Kürzinger K, Przybylski M.
    Biochemistry; 1996 Dec 10; 35(49):15633-9. PubMed ID: 8961925
    [Abstract] [Full Text] [Related]

  • 14. Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells.
    de Santis C, Lopalco L, Robbioni P, Longhi R, Rappocciolo G, Siccardi AG, Beretta A.
    AIDS Res Hum Retroviruses; 1994 Feb 10; 10(2):157-62. PubMed ID: 7515259
    [Abstract] [Full Text] [Related]

  • 15. Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.
    Laisney IL, Benjamin H, Gefter M, Strosberg AD.
    Eur J Immunol; 1996 Jul 10; 26(7):1634-40. PubMed ID: 8766572
    [Abstract] [Full Text] [Related]

  • 16. A novel human antibody against human immunodeficiency virus type 1 gp120 is V1, V2, and V3 loop dependent and helps delimit the epitope of the broadly neutralizing antibody immunoglobulin G1 b12.
    Zwick MB, Kelleher R, Jensen R, Labrijn AF, Wang M, Quinnan GV, Parren PW, Burton DR.
    J Virol; 2003 Jun 10; 77(12):6965-78. PubMed ID: 12768015
    [Abstract] [Full Text] [Related]

  • 17. [Localization of the HIV-1 gp120 conformational epitope recognized by virus neutralizing monoclonal antibodies 2G12].
    Tumanova OIu, Kuvshinov VN, Il'ichev AA, Nekrasov BG, Ivanisenko VA, Kozlov AP, Sandakhchiev LS.
    Mol Biol (Mosk); 2002 Jun 10; 36(4):657-63. PubMed ID: 12173470
    [Abstract] [Full Text] [Related]

  • 18. Characterization by serial deletion competition ELISAs of HIV-1 V3 loop epitopes recognized by monoclonal antibodies.
    Seligman SJ, Binley JM, Gorny MK, Burton DR, Zolla-Pazner S, Sokolowski KA.
    Mol Immunol; 1996 Jun 10; 33(9):737-45. PubMed ID: 8811069
    [Abstract] [Full Text] [Related]

  • 19. Conserved and exposed epitopes on intact, native, primary human immunodeficiency virus type 1 virions of group M.
    Nyambi PN, Mbah HA, Burda S, Williams C, Gorny MK, Nádas A, Zolla-Pazner S.
    J Virol; 2000 Aug 10; 74(15):7096-107. PubMed ID: 10888650
    [Abstract] [Full Text] [Related]

  • 20. Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies.
    Lopalco L, Longhi R, Ciccomascolo F, De Rossi A, Pelagi M, Andronico F, Moore JP, Schulz T, Beretta A, Siccardi AG.
    AIDS Res Hum Retroviruses; 1993 Jan 10; 9(1):33-9. PubMed ID: 7678970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.